Vicarious Surgical (NYSE:RBOT – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, November 12th. Analysts expect Vicarious Surgical to post earnings of ($2.61) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last issued its earnings results on Monday, August 12th. The company reported ($2.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.98) by $0.12. On average, analysts expect Vicarious Surgical to post $-10 EPS for the current fiscal year and $-8 EPS for the next fiscal year.
Vicarious Surgical Stock Down 0.2 %
Shares of RBOT traded down $0.02 during midday trading on Tuesday, reaching $8.04. 690 shares of the stock were exchanged, compared to its average volume of 25,422. Vicarious Surgical has a twelve month low of $4.27 and a twelve month high of $21.43. The business’s 50-day moving average price is $6.58 and its 200 day moving average price is $7.60.
Analyst Upgrades and Downgrades
View Our Latest Report on RBOT
About Vicarious Surgical
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Recommended Stories
- Five stocks we like better than Vicarious Surgical
- Top Stocks Investing in 5G Technology
- Insider Buying Signals Upside for These 3 Stocks
- Industrial Products Stocks Investing
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
- How to Calculate Retirement Income: MarketBeat’s Calculator
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.